. 2022 Jun 15;249:123687. doi: 10.1016/j.talanta.2022.123687

Table 1.

Comparison between the graphene/CRISPR-dCas9 biosensor and hospital disease reports for the detection of SARS-CoV-2 virus among real clinical samples.

Graphene-CRISPR biosensor	Gold standard		Total
Graphene-CRISPR biosensor	Delta	WT	Total
Delta	16	0	16
WT	0	10	10
Total	16	10	26

*:Clinical sensitivity = $\frac{t h e n u m b e r o f t r u e p o s i t i v e s a m p l e s}{t h e n u m b e r o f t r u e p o s i t i v e s a m p l e s + t h e n u m b e r o f f a l s e n e g a t i v e s a m p l e s}$ × 100%; Clinical specificity = $\frac{t h e n u m b e r o f t r u e n e g a t i v e s a m p l e s}{t h e n u m b e r o f t r u e n e g a t i v e s a m p l e s + t h e n u m b e r o f f a l s e p o s i t i v e s a m p l e s}$ × 100%.